Jenburkt Pharmaceuticals Ltd. - Research Center
524731 JENBURPH Group (X) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 136.75 | 123.98 | 109.29 | 118.89 | 122.64 |
| Expenses | |||||
| Material consumed | 33.00 | 31.43 | 30.10 | 33.07 | 36.26 |
| Manufacturing expenses | 1.56 | 1.24 | 0.84 | 1.11 | 1.39 |
| Personnel expenses | 38.81 | 36.49 | 32.38 | 36.51 | 31.20 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 33.01 | 27.56 | 26.13 | 28.46 | 28.83 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 106.38 | 96.73 | 89.45 | 99.15 | 97.68 |
| Operating profit | 30.37 | 27.26 | 19.84 | 19.74 | 24.96 |
| Other recurring income | 5.12 | 4.95 | 4.31 | 4.22 | 3.41 |
| Adjusted PBDIT | 35.49 | 32.20 | 24.15 | 23.96 | 28.37 |
| Financial expenses | 0.37 | 0.43 | 0.47 | 0.53 | 0.39 |
| Depreciation | 2.26 | 1.90 | 2.04 | 2.30 | 1.35 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 32.86 | 29.87 | 21.64 | 21.14 | 26.63 |
| Tax charges | 8.26 | 7.57 | 5.14 | 6.27 | 6.84 |
| Adjusted PAT | 24.61 | 22.30 | 16.50 | 14.87 | 19.80 |
| Non recurring items | -0.01 | - | - | - | - |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 24.60 | 22.30 | 16.50 | 14.87 | 19.80 |
| Earnigs before appropriation | 133.13 | 113.21 | 90.91 | 84.29 | 73.07 |
| Equity dividend | 5.51 | 4.68 | - | 10.12 | 3.32 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | - |
| Retained earnings | 127.62 | 108.53 | 90.91 | 74.16 | 69.75 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis